Clinically, patients in the pN1molN1 and pN0molN1 subgroups exhibited shorter BRFS compared to those in the pN0molN0 subgroup, but these differences did not reach statistical significance (pN0molN1 vs. pN0molN0, p = 0.19; pN1molN1 vs. pN0molN0, p = 0.14).
← all excerpts
Enhanced nodal staging by molecular detection of KLK3, FOLH1, and PCA3 in prostate cancer.
1
0.1900
0.1900